443 related articles for article (PubMed ID: 22329442)
1. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation.
Na JI; Choi SY; Yang SH; Choi HR; Kang HY; Park KC
J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1035-9. PubMed ID: 22329442
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and possible mechanisms of topical tranexamic acid in melasma.
Kim SJ; Park JY; Shibata T; Fujiwara R; Kang HY
Clin Exp Dermatol; 2016 Jul; 41(5):480-5. PubMed ID: 27135282
[TBL] [Abstract][Full Text] [Related]
3. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of oral tranexemic acid in refractory melasma: A clinico-immuno-histopathological study.
Nagaraju D; Bhattacharjee R; Vinay K; Saikia UN; Parsad D; Kumaran MS
Dermatol Ther; 2018 Sep; 31(5):e12704. PubMed ID: 30253023
[TBL] [Abstract][Full Text] [Related]
5. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial.
Lee JH; Park JG; Lim SH; Kim JY; Ahn KY; Kim MY; Park YM
Dermatol Surg; 2006 May; 32(5):626-31. PubMed ID: 16706756
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of tranexamic acid in the treatment of adult melasma: An updated meta-analysis of randomized controlled trials.
Feng X; Su H; Xie J
J Clin Pharm Ther; 2021 Oct; 46(5):1263-1273. PubMed ID: 33959984
[TBL] [Abstract][Full Text] [Related]
7. Tranexamic acid in melasma: A focused review on drug administration routes.
Konisky H; Balazic E; Jaller JA; Khanna U; Kobets K
J Cosmet Dermatol; 2023 Apr; 22(4):1197-1206. PubMed ID: 36606378
[TBL] [Abstract][Full Text] [Related]
8. Histochemical and immunohistochemical study in melasma: evidence of damage in the basal membrane.
Torres-Álvarez B; Mesa-Garza IG; Castanedo-Cázares JP; Fuentes-Ahumada C; Oros-Ovalle C; Navarrete-Solis J; Moncada B
Am J Dermatopathol; 2011 May; 33(3):291-5. PubMed ID: 21317614
[TBL] [Abstract][Full Text] [Related]
9. Oral Tranexamic Acid for the Treatment of Melasma: A Review.
Bala HR; Lee S; Wong C; Pandya AG; Rodrigues M
Dermatol Surg; 2018 Jun; 44(6):814-825. PubMed ID: 29677015
[TBL] [Abstract][Full Text] [Related]
10. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
[TBL] [Abstract][Full Text] [Related]
11. Assessment of combined fractional CO
Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
[TBL] [Abstract][Full Text] [Related]
12. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial.
Kanechorn Na Ayuthaya P; Niumphradit N; Manosroi A; Nakakes A
J Cosmet Laser Ther; 2012 Jun; 14(3):150-4. PubMed ID: 22506692
[TBL] [Abstract][Full Text] [Related]
13. Oral tranexamic acid lightens refractory melasma.
Tan AWM; Sen P; Chua SH; Goh BK
Australas J Dermatol; 2017 Aug; 58(3):e105-e108. PubMed ID: 27173008
[TBL] [Abstract][Full Text] [Related]
14. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S
J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of oral vs different dilutions of intradermal tranexamic acid microinjections in melasma-A randomized clinical trial.
El Hadidi H; Mosaad R; Ragab N
Dermatol Ther; 2021 May; 34(3):e14924. PubMed ID: 33651442
[TBL] [Abstract][Full Text] [Related]
16. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study.
Wanitphakdeedecha R; Sy-Alvarado F; Patthamalai P; Techapichetvanich T; Eimpunth S; Manuskiatti W
Lasers Med Sci; 2020 Dec; 35(9):2015-2021. PubMed ID: 32506227
[TBL] [Abstract][Full Text] [Related]
17. Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation.
Desai S; Ayres E; Bak H; Manco M; Lynch S; Raab S; Du A; Green D; Skobowiat C; Wangari-Talbot J; Zheng Q
J Drugs Dermatol; 2019 May; 18(5):454-459. PubMed ID: 31141852
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study.
Sharma R; Mahajan VK; Mehta KS; Chauhan PS; Rawat R; Shiny TN
Clin Exp Dermatol; 2017 Oct; 42(7):728-734. PubMed ID: 28649780
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women.
Handog EB; Galang DA; de Leon-Godinez MA; Chan GP
Int J Dermatol; 2009 Aug; 48(8):896-901. PubMed ID: 19659873
[TBL] [Abstract][Full Text] [Related]
20. Topical tranexamic acid as an adjuvant treatment in melasma: Side-by-side comparison clinical study.
Chung JY; Lee JH; Lee JH
J Dermatolog Treat; 2016 Aug; 27(4):373-7. PubMed ID: 26526300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
